{{Rsnum
|rsid=2637988
|Gene=IL1RN
|Chromosome=2
|position=113119202
|Orientation=plus
|GMAF=0.478
|Gene_s=IL1RN
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 32.7 | 52.2 | 15.0
| HCB | 16.1 | 51.1 | 32.8
| JPT | 11.5 | 46.0 | 42.5
| YRI | 11.0 | 52.1 | 37.0
| ASW | 15.8 | 45.6 | 38.6
| CHB | 16.1 | 51.1 | 32.8
| CHD | 14.7 | 48.6 | 36.7
| GIH | 26.7 | 44.6 | 28.7
| LWK | 20.0 | 53.6 | 26.4
| MEX | 19.0 | 62.1 | 19.0
| MKK | 33.3 | 48.7 | 17.9
| TSI | 30.4 | 60.8 | 8.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23602982
|Title=IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort
}}

{{PMID Auto
|PMID=19468064
|Title=Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions.
|OA=1
}}

{{PMID Auto
|PMID=19567509
|Title=Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.
|OA=1
}}

{{PMID Auto
|PMID=21250972
|Title=A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
|OA=1
}}

{{PMID Auto
|PMID=22322675
|Title=IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}